» Articles » PMID: 6154075

A 49,000-dalton Polypeptide Bearing All Antigenic Determinants and Full Immunogenicity of 22-nm Hepatitis B Surface Antigen Particles

Overview
Journal J Immunol
Date 1980 Apr 1
PMID 6154075
Citations 19
Authors
Affiliations
Soon will be listed here.
Abstract

Spherical 22-nm hepatitis B surface antigen (HBsAg) particles with a subtype adr were purified from plasma of asymptomatic carriers of hepatitis B virus. When purified HBsAg preparation was treated with sodium dodecylsulfate in the absence of reducing agents, it yielded spherical particles with a diameter smaller than 22 nm, and in addition, a polypeptide with a molecular size of 49,000 daltons, which seemed to constitute the outer coat of HBsAg particles. The recovery of the polypeptide on the basis of optical density at 280 nm was 2%, starting from 22-nm HBsAg particles. The 49,000-dalton polypeptide apparently represented a structural unit of the surface of HBsAg particles, since it bore all common (a, Re) and subtypic (d, r) determinants with essentially the same antigenic titers as intact HBsAg particles. Furthermore, this polypeptide was equally immunogenic as 22-nm HBsAg particles in raising corresponding antibodies in mice. When the 49,000-dalton polypeptide was reduced in the presence of 2-mercaptoethanol, it cleaved into 22,000- and 27,000-dalton polypeptides with a drastic decrease in both antigenicity and immunogenicity. These results indicate the different molecular arrangements between outer coat and inner portion of HBsAg particles, and a potential application of the 49,000-dalton polypeptide as a component vaccine, owing to its strong antigenicity both in vitro and in vivo.

Citing Articles

Comparative purification and characterization of hepatitis B virus-like particles produced by recombinant vaccinia viruses in human hepatoma cells and human primary hepatocytes.

Reuschel E, Jilg W, Seelbach-Goebel B, Deml L PLoS One. 2019; 14(2):e0212800.

PMID: 30794666 PMC: 6386438. DOI: 10.1371/journal.pone.0212800.


Derivation of non-infectious envelope proteins from virions isolated from plasma negative for HIV antibodies.

Vyas G, Stoddart C, Killian M, Brennan T, Goldberg T, Ziman A Biologicals. 2011; 40(1):15-20.

PMID: 22192456 PMC: 4861611. DOI: 10.1016/j.biologicals.2011.11.005.


Characterization of early hepatitis B virus surface protein oligomers.

Wounderlich G, Bruss V Arch Virol. 1996; 141(7):1191-205.

PMID: 8774681 DOI: 10.1007/BF01718824.


Characterization of stable Chinese hamster ovary cells expressing wild-type, secreted, and glycosylphosphatidylinositol-anchored human immunodeficiency virus type 1 envelope glycoprotein.

Weiss C, White J J Virol. 1993; 67(12):7060-6.

PMID: 8230430 PMC: 238167. DOI: 10.1128/JVI.67.12.7060-7066.1993.


Allelic subtypic determinants of hepatitis B surface antigen (i and t) that are distinct from d/y or w/r.

Ohnuma H, Machida A, Okamoto H, Tsuda F, Sakamoto M, Tanaka T J Virol. 1993; 67(2):927-32.

PMID: 7678309 PMC: 237446. DOI: 10.1128/JVI.67.2.927-932.1993.